Trial Profile
A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2019
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- Sponsors Allergan
- 16 Apr 2015 New trial record